McIntyre TM, Stafforini DM, Zimmerman GA, Prescott SM: Purification of platelet-activating factor acetylhydrolase. In Enzymes of Lipid Metabolism, Louis Freysz, editor, Plenum Press, 1986

Stafforini DM, Prescott SM, McIntyre TM: Human plasma platelet-activating factor acetylhydrolase: Purification and properties. J Biol Chem 262:4223-4230, 1987

Stafforini DM, Carter ME, McIntyre TM, Prescott SM: Human plasma platelet-activating factor acetylhydrolase: Association with lipoprotein particles and role in the degradation of platelet-activating factor. J Biol Chem 262:4215-4222, 1987

Stafforini DM, Carter ME, Zimmerman GA, McIntyre TM, Prescott SM: Lipoproteins alter the catalytic behavior of the PAF acetylhydrolase in human plasma. Proc Natl Acad Sci USA 86:2393-2397, 1989

Stremler KE, Stafforini DM, Prescott SM, Zimmerman GA, McIntyre TM: An oxidized derivative of phosphatidylcholine is a substrate for the PAF acetylhydrolase from human plasma. J Biol Chem 264:5331-5334, 1989

Elstad MR, Stafforini DM, Prescott SM, McIntyre TM, Zimmerman GA: PAF-acetylhydrolase increases during macrophage differentiation: a novel mechanism that regulates accumulation of platelet-activating factor. J Biol Chem 264:8467-8470, 1989

Elstad MR, Stafforini DM, Stremler KE, Zimmerman GA, McIntyre TM, Prescott SM: The potential role of the PAF acetylhydrolase in human disease. Platelet-activating Factor and Disease, K. Saito & D. Hanahan, editors, International Medical Publishers, Tokyo, 1989

Stafforini DM, McIntyre TM, Prescott SM: Platelet-activating factor acetylhydrolase from human plasma. Method Enzymol 187:344-357, 1990

Stafforini DM, Elstad ME, Zimmerman GA, McIntyre TM, Prescott SM: Human macrophages secrete platelet-activating factor acetylhydrolase. J Biol Chem 265:9682-9687, 1990

Stafforini DM, Prescott SM, Zimmerman GA, McIntyre TM: Platelet-activating factor acetylhydrolase activity in human tissues and blood cells. Lipids 26:979-985, 1991

Stremler KE, Stafforini DM, Prescott SM, McIntyre TM: Human plasma PAF acetylhydrolase: oxidatively-fragmented phospholipids as substrates. J Biol Chem 266:11095-11103, 1991

Stafforini DM, Prescott SM, McIntyre TM: Platelet-activating factor acetylhydrolase in human erythrocytes. Method Enzymol 197:411-425411-425, 1991

Tarbet EB, Stafforini DM, Elstad MR, Zimmerman GA, McIntyre TM, Prescott SM: Liver cells secrete the plasma form of platelet-activating factor acetylhydrolase. J Biol Chem 266:16667-16673, 1991

Stafforini DM, Zimmerman GA, McIntyre TM, Prescott SM: Platelet-activating factor and cardiovascular disease. In The Hemostatic System, Endothelial Function, and Cardiovascular Disease, R.B. Francis, editor, Marcel Decker, 1992

Stafforini DM, Zimmerman GA, McIntyre TM, Prescott SM: The platelet-activating factor acetylhydrolase from human plasma prevents oxidative modification of low-density lipoprotein. Trans Assoc Amer Phys 15:44-63, 1992

Stafforini DM, Rollins EN, Prescott SM, McIntyre TM: The platelet-activating factor acetylhydrolase from human erythrocytes: purification and properties. J Biol Chem 268:3857-3865, 1993

Prescott SM, Patel KD, Smiley PL, Stafforini DM, Lorant DE, Zimmerman GA, McIntyre TM: Potential roles for oxidized phospholipids in inflammation and atherogenesis. Atherosclerosis Reviews 25:59-68, 1993

Lorant DE, Topham MK, Whatley RE, McEver RP, Prescott SM, McIntyre TM, Zimmerman GA: Inflammatory roles of P-selectin. J Clin Invest 92:559-570, 1993

Zimmerman GA, Elstad MR, Lorant DE, Patel KD, Topham MK, Whatley RE, McIntyre TM, Prescott SM: Platelet-activating factor: New roles in cell adhesion. J Lipid Mediators Cell Signalling 10:557-59, 1994

Yamada Y, Stafforini DM, Imaizumi T, Zimmerman GA, McIntyre TM, Prescott SM: Characterization of the platelet-activating factor acetylhydrolase from human plasma by heterologous expression in Xenopus laevis oocytes. Proc Natl Acad Sci USA 91:10320-10324, 1994

McIntyre TM, Patel KD, Smiley PL, Stafforini DM, Prescott SM, Zimmerman GA: Oxidized phospholipids with PAF-like bioactivity. J Lipid Mediators Cell Signalling 10:37-39, 1994

Stafforini DM, Zimmerman GA, McIntyre TM, Prescott SM: The plasma PAF acetylhydrolase prevents oxidative modification of low density lipoproteins. J Lipid Mediators Cell Signalling 10:53-56, 1994

Watson AD, Navab M, Hama SY, Sevanian A, Prescott SM, Stafforini DM, McIntyre TM, LaDu BN, Fogelman AM, Berliner JA: Effect of platelet-activating factor acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J Clin Invest 95:774-782, 1995

Tjoelker LW, Wilder C, Eberhardt C, Stafforini DM, Dietsch G, Schimpf B, Hooper S, Trong HL, Cousens LS, Zimmerman GA, Yamada Y, McIntyre TM, Prescott SM, Gray PW: Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature 374:549-553, 1995

Heery JM, Kozak M, Stafforini DM, Jones DA, Zimmerman GA, McIntyre TM, Prescott SM: Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells. J Clin Invest 96:2322-2330, 1995

Tjoelker LW, Eberhardt C, Unger J, Trong HL, Zimmerman GA, McIntyre TM, Stafforini DM, Prescott SM, Gray PW: Plasma platelet-activating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad. J Biol Chem 270:24581-24587, 1995

Imaizumi T-a, Stafforini DM, Yamada Y, McIntyre TM, Prescott SM, Zimmerman GA. Platelet-activating factor: a mediator for clinicians. J Int Med 238:5-20, 1995

Van Lenten BJ, Hama SY, de Beer FC, Stafforini DM, McIntyre TM, Prescott SM, La Du BN, Fogelman AM, Navab M: Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. J Clin Invest 96:2758-2767, 1995

Imaizumi T-a, Stafforini DM, Yamada Y, Zimmerman GA, McIntyre TM, Prescott SM: The fate of platelet-activating factor: PAF acetylhydrolases from plasma and tissues. Chapter in Lipobiology, Vol.1 pp. 141-162, 1996, Richard Gross, editor, JAI Press, Connecticut

Stafforini DM, Satoh K, Atkinson DL, Tjoelker LW, Eberhardt C, Yoshida H, Imaizumi T-a, Takamatsu S, Zimmerman GA, McIntyre TM, Gray PW, Prescott SM: PAF acetylhydrolase deficiency: a missense mutation near the active site of an anti-inflammatory enzyme. J Clin Invest 97:2784-2791, 1996

Zimmerman GA, McIntyre TM, Prescott SM, Stafforini DM: Platelet-activating factor: antagonists, terminators, and microbial opportunism. J Int Med 239:463-466, 1996

Stafforini DM, Prescott SM, Zimmerman GA, McIntyre TM: Mammalian platelet- activating factor acetylhydrolases. Biochim Biophys Acta 1301:162-173, 1996

Prescott SM, McIntyre TM, Zimmerman GA, Stafforini DM: Inflammation as an early component of atherosclerosis and vascular damage: a role for P-selectin and platelet-activating factor. Japan Circ J 60:137-141, 1996

Zimmerman GA, Elstad MR, Lorant DE, McIntyre TM, Prescott SM, Topham MK, Weyrich AS, Whatley RE: Platelet-activating factor (PAF): signalling and adhesion in cell-cell interactions. Adv Exper Med Biol 416:297-304, 1996

Tjoelker LW, Eberhardt C, Wilder C, Dietsch G, Trong HL, Cousens LS, Zimmerman GA, McIntyre TM, Stafforini DM, Prescott SM, Gray PW: Functional and structural features of plasma platelet-activating factor acetylhydrolase. Adv Exper Med Biol 416:107-111, 1996

Ding L, Bunting M, Topham M K, McIntyre TM, Zimmerman GA, Prescott SM: Alternative splicing of the human diacylglycerol kinase z gene in muscle. Proc Natl Acad Sci USA 94:5519-5524, 1997

Stafforini DM, McIntyre TM, Zimmerman GA, Prescott SM: Platelet-activating factor acetylhydrolases. J Biol Chem 272:17895-17898, 1997

Prescott SM, Zimmerman GA, McIntyre TM, Stafforini DM: Inflammation in the vascular wall as an early event in atherosclerosis. Diabetologia 40:S111-112, 1997

Topham MK, Carveth HJ, McIntyre TM, Prescott SM, Zimmerman GA: Human endothelial cells regulate polymorphonuclear leukocyte degranulation. FASEB J 12:733-746, 1998

Cao Y, Stafforini DM, Zimmerman GA, McIntyre TM, Prescott SM: Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation. J Biol Chem 273:4012-4020, 1998

Gill EA, Imaizumi T-a, Carveth HJ, Topham MK, Tarbet EB, McIntyre TM, Prescott SM, Zimmerman GA: Bacterial lipopolysaccharide induces endothelial cells to synthesize a degranulating factor for neutrophils. FASEB J 12:673-684, 1998

Topham MK, Bunting M, Zimmerman GA, McIntyre TM, Blackshear P, Prescott SM: Protein kinase C regulates the nuclear localization of diacylglycerol kinase z. Nature 394:697-699, 1998

Stafforini DM, Tjoelker LW, McCormick SPA, Vaitkus D, McIntyre TM, Gray PW, Young SG, Prescott SM: The molecular basis of the interaction between plasma PAF acetylhydrolase and low density lipoprotein. J Biol Chem 274:7018-7024, 1999

Zimmerman GA, Albertine KH, Carveth HJ, Gill EA, Grissom CK, Hoidal JR, Imaizumi T-a, Maloney CG, McIntyre TM, Michael JR, Orme JF, Prescott SM, Topham M: Endothelial Activation in ARDS. Chest 116:18S-23S, 1999

Stafforini DM, Numao T, Tsodikov A, Vaitkus D, Fukuda T, Watanabe N, Fueki N McIntyre TM, Zimmerman GA, Makino S, Prescott SM: Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma. J Clin Invest 103:989-997, 1999

Topham MK, Prescott SM: Mammalian diacylglycerol kinases: a family of lipid kinases with signaling functions. J Biol Chem 274:11447-11450, 1999

Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM: Platelet-activating factor and related lipid mediators. Ann Rev Biochem 69:419-441, 2000

Rodriguez de Turco EB, Tang W, Topham MK, Sakane F, Marcheselli VL, Chen C, Taketomi A, Prescott SM, Bazan NG: Diacylglycerol kinase epsilon regulates seizure susceptibility and long-term potentiation through arachidonoyl-inositol lipid signaling. Proc Natl Acad Sci USA 98:4740-4745, 2001

Topham MK, Prescott SM: Diacylglycerol kinase regulates Ras activation by a novel mechanism. J Cell Biol 152: 1135-1144, 2001

Stafforini DM, McIntyre TM, Zimmerman GA, Prescott SM: PAF acetylhydrolases. In Encyclopedia of Molecular Medicine T. Creighton, editor, John Wiley & Sons, New York, 2001

Pearman AT, Castro-Faria-Neto HC, McIntyre TM, Prescott SM, Stafforini DM: Characterization of human UMP-CMP kinase enzymatic activity and 5' untranslated region. Life Sci 69:2361-2370, 2001

Hogan A, Shepherd L, Chabot J, Quenneville S, Prescott SM, Topham MK, Gee SH: Interaction of g1-syntrophin with diacylglycerol kinase-z: Regulation of nuclear localization by PDZ interactions. J Biol Chem 276:26526-33, 2001

Topham MK, Prescott SM. Diacylglycerol kinases: regulation and signaling roles. Thromb Haemost. 88:912-8, 2002

Prescott SM, McIntyre TM, Zimmerman GA, Stafforini DM: Molecular events in acute inflammation. Arterioscl Thromb Vasc Biol 22:727-33, 2002

Zimmerman GA, McIntyre TM, Prescott SM, Stafforini DM. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med. 30:S294-301, 2002

Luo B, Prescott SM, Topham MK. Association of diacylglycerol kinase zeta with protein kinase C alpha: spatial regulation of diacylglycerol signaling. J Cell Biol. 160:929-37, 2003

Luo B, Prescott SM, Topham MK. Protein kinase C alpha phosphorylates and negatively regulates diacylglycerol kinase zeta. J Biol Chem. 278:39542-7, 2003

Stafforini DM, McIntyre TM, Zimmerman GA, Prescott SM. Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes. Crit Rev Clin Lab Sci. 40:643-72, 2003

Wu X, McIntyre TM, Zimmerman GA, Prescott SM, Stafforini DM. Molecular characterization of the constitutive expression of the plasma platelet-activating factor acetylhydrolase gene in macrophages. Biochem J. 375:351-63, 2003

Luo B, Prescott SM, Topham MK. Diacylglycerol kinase zeta regulates phosphatidylinositol 4-phosphate 5-kinase Ialpha by a novel mechanism. Cell Signal. 16:891-7, 2004

Luo B, Regier DS, Prescott SM, Topham MK. Diacylglycerol kinases. Cell Signal. 9:983-9, 2004

Wu X, Zimmerman GA, Prescott SM, Stafforini DM. The p38 MAPK pathway mediates transcriptional activation of the plasma platelet-activating factor acetylhydrolase gene in macrophages stimulated with lipopolysaccharide. J Biol Chem. 279:36158-65, 2004